Plain-English translation of NCT05200351 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing equine-assisted therapy—a treatment where teenagers work directly with horses—for young people with autism who have struggled to regulate their emotions despite receiving therapy for at least 18 months. The study will have about 35 teenagers participate in 15 sessions of this horse-based therapy. Researchers want to see if this approach can help improve emotional control in ways that traditional therapy alone has not.
Some teenagers with autism find it very difficult to manage their emotions even after receiving standard therapy. This trial exists because early research suggests that working with horses in a structured therapeutic way might offer benefits that other treatments haven't provided, especially for young people whose emotions remain hard to control.
You likely qualify if…
You likely don't qualify if…
If you join, you'll be randomly assigned to start the therapy after waiting 2 to 6 weeks, which helps researchers understand if the therapy is truly making a difference. You'll then attend 15 sessions of equine-assisted therapy, where you'll work directly with horses under professional supervision. Throughout the study, you'll also answer some questions about how you're feeling and managing your emotions, and researchers may ask you or your family about your experience with the therapy.
AI-generated summary from trial data · Jun 14, 2026 · Not medical advice
Netherlands
Sponsor
Karakter Kinder- en Jeugdpsychiatrie
Collaborators
ZonMw: The Netherlands Organisation for Health Research and Development
Enrollment target
~35 participants
Started
February 2022
Primary completion
December 2024
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
11 Years – 18 Years
Last updated on clinicaltrials.gov in November 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Jenny den Boer, Drs
Radboud/Karakter
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.